BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18691607)

  • 1. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
    Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
    Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity.
    Djurendić E; Daljev J; Sakac M; Canadi J; Santa SJ; Andrić S; Klisurić O; Kojić V; Bogdanović G; Djurendić-Brenesel M; Novaković S; Gasi KP
    Steroids; 2008 Jan; 73(1):129-38. PubMed ID: 17963806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
    Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM
    J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
    Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
    Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
    Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
    J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.
    Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
    J Med Chem; 2005 Oct; 48(20):6379-85. PubMed ID: 16190763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
    Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
    Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
    Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
    J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
    Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
    Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
    Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
    Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biochemical studies of new 7α-allylandrostanes as aromatase inhibitors.
    Varela CL; Amaral C; Correia-da-Silva G; Carvalho RA; Teixeira NA; Costa SC; Roleira FM; Tavares-da-Silva EJ
    Steroids; 2013 Jul; 78(7):662-9. PubMed ID: 23499824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
    Neves MA; Dinis TC; Colombo G; Sá e Melo ML
    Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
    Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
    J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A time-dependent inactivation of aromatase by 19-substituted androst-4-ene-3,6,17-triones.
    Numazawa M; Mutsumi A; Asano N; Ito Y
    Steroids; 1993 Jan; 58(1):40-6. PubMed ID: 8430444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
    Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW
    Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of azole isoflavone inhibitors of aromatase.
    Hackett JC; Kim YW; Su B; Brueggemeier RW
    Bioorg Med Chem; 2005 Jun; 13(12):4063-70. PubMed ID: 15911319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors.
    Numazawa M; Mutsumi A
    Biochem Biophys Res Commun; 1991 May; 177(1):401-6. PubMed ID: 2043124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
    Neves MA; Dinis TC; Colombo G; Sá e Melo ML
    J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.